Table 1.
Patient Characteristics
|
NNVAMD
|
|||||
|---|---|---|---|---|---|
| Control (N=100) | All (n=216) | GA (n=38) | NVAMD (n=146) | Significance of Difference* | |
| Demographics | |||||
| Female (%) | 78.0 | 75.5 | 84.2 | 78.1 | None |
| White (%) | 92.0 | 95.8 | 94.7 | 93.8 | None |
| Age, mean (SD) | 78.4 (8.6) | 79.1 (9.2) | 81.7 (7.7) | 80.9 (9.4) | + |
| Medical factors | |||||
| BMI (mean), kg/m2 | 25.8 | 26.1 | 26.1 | 27.2 | None |
| Hypertension, % | 79.6 | 78.9 | 81.6 | 83.5 | None |
| Cardiovascular, % | 27.8 | 35.1 | 26.3 | 31.9 | None |
| Creatinine, mean (SD) | 1.1 (0.5) | 1.1 (1.0) | 1.3 (1.3) | 1.1 (0.6) | None |
| Medications, mean (SD) | 5.7 (2.4) | 6.0 (3.2) | 6.2 (2.9) | 6.1 (3.1) | None |
| On vitamin D Supplements, % | 82.7 | 71.7 | 85.7 | 77.2 | None |
| Smoking, % | 22.7 | 26.9 | 27.0 | 36.6 | + # |
*
Pairwise comparisons completed to compare NVAMD versus NNVAMD, NVAMD versus control, and control versus NNVAMD Patients. None is noted if P > 0.05 for all comparisons.
+
P < 0.05 NVAMD versus control patients.
#
P < 0.05 NVAMD versus NNVAMD patients
$ P > 0.05 for all differences between control and NNVAMD patients.
BMI, body mass index.